Skip to content

Verification Protocol for the Cloud DX Vitaliti Continuous Vital Signs Monitor (VERDICT-2)

Verification Protocol for the Cloud DX Vitaliti Continuous Vital Signs Monitor (Model CVSM-1A) for Clinical Use and Self Measurement in Ambulatory Settings

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05886153
Acronym
VERDICT-2
Enrollment
35
Registered
2023-06-02
Start date
2023-08-22
Completion date
2023-09-19
Last updated
2024-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Pressure, Heart Rate, Oxygen Saturation, Pulse Rate, Respiration, Temperature

Brief summary

The VERDICT-2 verification study will examine the accuracy of the Cloud DX Vitaliti Continuous Vital Signs Monitor (Model: CVSM-1A) in an ambulatory context with healthy participants. The objective is to determine the accuracy of continuous non-invasive vital signs metrics including respiration, pulse rate, oxyhemoglobin saturation (SpO2), core temperature, heart rate, and cNIBP against standard comparator devices guided by consensus standards.

Detailed description

Effective postoperative care is faced with several challenges- patients experience major complications following surgery, which often require re-hospitalization or utilization of healthcare services (i.e., emergency room visits) once discharged into the community. New remote automated monitoring (RAM) technologies that enable data integration, synthesis, and real-time alerts to clinicians have the potential to transform postoperative care, similar to how intraoperative care has evolved. The Cloud DX Vitaliti Continuous Vital Signs Monitor (Model: CVSM-1A) is a continuous vital sign monitor intended to measure vital metrics including systolic and diastolic blood pressures (via ECG/ photoplethysmography \[PPG\]), pulse (via PPG), respiration rate (via impedance respiration waveform), core body temperature (via infrared sensor), and blood oxygen saturation levels (via PPG) of an adult individual using non-invasive techniques. The VERDICT-2 verification study will examine the accuracy of the Vitaliti CVSM in an ambulatory context with healthy participants.

Interventions

DEVICEVitaliti Continuous Vital Sign Monitor Model CVSM-1A

Measurements recorded by the Vitaliti CVSM device will be compared to the recordings from various standardized comparator devices.

Sponsors

McMaster University
CollaboratorOTHER
Population Health Research Institute
CollaboratorOTHER
Cloud DX Inc.
CollaboratorINDUSTRY
Hamilton Health Sciences Corporation
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Intervention model description

Single group verification testing of the Vitaliti Continuous Vital Sign Monitor Model CVSM-1A device

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
Yes

Inclusion criteria

1. Age ≥ 18 years 2. Healthy participant (no known significant health problems) 3. Provide informed consent to participate

Exclusion criteria

1. Active smoker 2. Recent exposure to carbon monoxide 3. Have unexplained shortness of breath at rest 4. Pregnant 5. Hearing aid/Cochlear Implant 6. Current arrhythmia 7. ICD/Pacemaker 8. Current respiratory disease/infection 9. Significant body tremors/shaking 10. Epilepsy 11. History of unexplained fainting/syncope 12. Have any disorder that prohibits placement of the device (i.e., skin rash/abrasion, open or infected sore) 13. Cerebrospinal Fluid Shunt 14. Unable to ambulate, stand, or lay in supine position 15. Allergy to adhesive 16. Unable to understand or speak English

Design outcomes

Primary

MeasureTime frameDescription
Respiration Rate44 MinutesDetermining the accuracy of the impedance respiration waveform on the Vitaliti device to measure respiration rate, compared to an appropriate standardized comparator device. The Vitaliti CVSM will be evaluated against performance criteria determined to be clinically relevant, in alignment with predicate devices, and as defined by the manufacturer, since there are no internationally recognized consensus standards.
Pulse Rate27 MinutesDetermining the accuracy of the ECG/photoplethysmography (PPG) on the Vitaliti device to measure pulse rate, compared to an appropriate standardized comparator device. Detailed analysis will be conducted to verify accuracy of the Vitaliti device against performance criteria as defined in IEC 60601-2-27:2011/ (R2016).
Oxyhemoglobin Saturation27 MinutesDetermining the accuracy of the electrocardiogram (ECG)/photoplethysmography (PPG) on the Vitaliti device to measure blood oxygen saturation, compared to an appropriate standardized comparator device. A detailed analysis will be performed to compare the Vitaliti device against performance criteria as defined in ISO 80601-2-61:2017, MOD.
Temperature12 MinutesDetermining the accuracy of the infrared sensor on the Vitaliti device to measure core body temperature, compared to an appropriate standardized comparator device. A detailed analysis will be conducted to verify accuracy of the Vitaliti device against performance criteria as defined in ISO 80601-2-56:2017/AMD-1:2018.
Heart Rate36 MinutesDetermining the accuracy of the electrocardiogram (ECG) on the Vitaliti device to measure heart rate, compared to an appropriate standardized comparator device. A detailed analysis will be conducted to verify accuracy of the Vitaliti device against performance criteria as defined in IEC 60601-2-27:2011/ (R2016).
Blood Pressure30 MinutesDetermining the accuracy of the electrocardiogram (ECG)/photoplethysmography (PPG) on the Vitaliti device to measure blood pressure, compared to an appropriate standardized comparator device. A detailed analysis will be conducted to verify accuracy against performance criteria as defined in ISO 81060-2: 2018/AMD-1:2020.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026